Entheon Biomedical Corp. (CSE:ENBI)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Dec 18, 2025, 3:06 PM EST
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
1.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | - | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEntheon Biomedical News
- 2 months ago - Entheon Announces Execution of Business Combination Agreement with Nutravisor - Newsfile Corp
- 4 months ago - Entheon Announces Letter of Intent with Nutravisor Inc. - Newsfile Corp
- 1 year ago - Entheon Announces Change of Directors - Newsfile Corp
- 1 year ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 1 year ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 1 year ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 4 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 4 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp